Preclinical studies and transcriptome analysis in a model of Parkinson’s disease with dopaminergic ZNF746 expression
Ji-Hun Kim(Sungkyunkwan University), Yunjong Lee(Sungkyunkwan University), Dang-Khoa Vo(Gachon University), Key‐Hwan Lim(Chungbuk National University), Hyeon‐Man Baek(Southwestern Medical Center), Jae‐Yeol Joo(Hanyang University), Han‐Joo Maeng(Gachon University), Joo‐Ho Shin(Chonnam National University), Sung‐Hyun Kim(Hanyang University), Hyojung Kim(Samsung (South Korea)), Areum Jo(Sungkyunkwan University), Gum Hwa Lee, Sumin Yang(Keimyung University), Jooheon Shin(Lieber Institute for Brain Development), Valina L. Dawson(Johns Hopkins University)
Cited by 11
Related Papers
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
|Cell Death and Differentiation|2018|6.6k
Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease
|Nature Medicine|2018|1.2k
PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's Disease
|Cell|2011|951
Analysis of Tumor Metabolism Reveals Mitochondrial Glucose Oxidation in Genetically Diverse Human Glioblastomas in the Mouse Brain In Vivo
|Cell Metabolism|2012|532
Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function
|Proceedings of the National Academy of Sciences|2010|282